Why Did Amarin's Stock Fall Off a Cliff?
On Monday, Amarin (NASDAQ: AMRN) investors got some horrible news. A federal judge in Nevada declared that the company's intellectual property was "obvious" and its drug patent was invalid.
This was a complete shock to many investors, including yours truly. Amarin only has one drug, and now the company has lost the rights to it in the United States. Yesterday I was saying, "This is legalized theft."
Image source: Getty Images.
Source Fool.com
